查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1701670

全球快速流感診斷測試 (RIDT) 市場：產業分析、規模、佔有率、成長、趨勢和預測（2025-2032 年）

Rapid Influenza Diagnostic Tests Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 242 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

主要發現

  • 快速流感診斷測試（RIDT）市場規模：9.82億美元（2025年）
  • 預計市值：17.495億美元（2032年）
  • 全球市場成長率：8.6%（2025年至2032年的複合年成長率）

快速流感診斷測試（RIDT）市場 - 報告範圍

流感快速診斷測試（RIDT）市場包括旨在短時間內（通常在 30 分鐘內）檢測呼吸道檢體中的流感病毒抗原的診斷工具。這些測試對於及時診斷和管理流感感染照護現場，特別是在季節性流行和大流行期間。免疫測量技術的進步、人們對早期發現疾病的認知不斷提高以及全球健康威脅的增加，都對市場發展勢頭做出了重大貢獻。

市場成長動力

全球 RIDT 市場的成長很大程度上是由於季節性和大流行性流感疫情的增加，這推動了對快速且準確的照護現場診斷的需求。政府和衛生當局加強了公共衛生行動和監測計劃，更加重視早期發現以控制感染。此外，數位和分子診斷領域的技術創新，例如更敏感和特異性的RIDT 的開發，正在擴大臨床應用的範圍和可靠性。這些測試在居家醫療和遠距醫療保健環境中的日益普及進一步加速了市場滲透。此外，全球老年人口的成長，使他們面臨更高的嚴重流感併發症風險，也增加了對快速簡便的診斷方法的需求。

市場限制

儘管需求強勁，RIDT 市場仍面臨重大限制。主要的限制在於，與 RT-PCR 等實驗室方法相比，傳統快速檢測的敏感度相對較低，這會導致假陰性，並對後續臨床決策構成挑戰。這種限制可能會削弱臨床醫生對測試結果的信心，尤其是在重症加護環境中。此外，由於流感病毒的突變導致檢測性能的變化，因此對保持一致的診斷準確性提出了挑戰。監管障礙和產品召回也會阻礙市場的發展，特別是對於那些尋求將創新診斷技術商業化的新參與企業而言。此外，在資源有限的環境中，成本限制和對早期檢測益處缺乏認知可能會限制 RIDT 的採用。

市場機會

面對這些挑戰，RIDT 市場提供了多個有利可圖的成長機會。分子診斷的整合度日益提高，尤其是基於 NAAT 的快速測試，由於其高靈敏度和快速的周轉時間，被定位為臨床和臨床前環境中的首選。遠端醫療和分散醫療保健的擴展為家庭流感檢測開闢了新的管道，並得到了易於使用的數位檢測套組的支援。新興經濟體，尤其是亞太和拉丁美洲的新興經濟體，由於對醫療保健基礎設施的投資不斷增加和意識不斷增強，提供了尚未開發的市場潛力。此外，診斷公司和公共衛生機構之間的策略聯盟可能會促進創新並加速下一代 RIDT 的部署。對大流行病防範和感染疾病監測的投資也為市場擴張創造了肥沃的土壤。

本報告研究了全球快速流感診斷測試 (RIDT) 市場，並對市場動態進行了詳細分析，包括成長動力、趨勢、機會和挑戰。

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
    • 任務
    • 主要趨勢
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長前景
  • COVID-19影響分析
  • 預測因子－相關性和影響力

第3章 增值考慮

  • 產品採用分析
  • 疾病流行病學
  • 技術進步
  • 監管格局
  • 價值鏈分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

4. 全球快速流感診斷檢驗（RIDT）市場展望

  • 主要亮點
    • 市場規模及與前一年同期比較
    • 絕對的商機
  • 市場規模分析及預測
    • 市場規模表現分析（2019-2024）
    • 當前市場規模分析與預測（2025-2032）
  • 全球快速流感診斷測試（RIDT）市場展望（按產品類型）
    • 簡介/主要發現
    • 按產品類型分類的市場規模表現與分析（2019-2024 年）
    • 按產品類型分類的當前市場規模分析和預測（2025-2032）
    • 按產品類型進行市場吸引力分析
  • 全球快速流感診斷測試（RIDT）市場展望：測試類型
    • 簡介/主要發現
    • 按測試類型分類的市場規模績效分析（2019-2024）
    • 按測試類型分類的當前市場規模分析和預測（2025-2032）
    • 市場吸引力分析：測試類型
  • 全球快速流感診斷測試（RIDT）市場展望（按檢測類型）
    • 簡介/主要發現
    • 按檢測類型分類的市場規模績效分析（2019-2024 年）
    • 按檢測類型分類的當前市場規模分析和預測（2025-2032）
    • 市場吸引力分析：檢測類型
  • 全球快速流感診斷測試（RIDT）市場展望：樣本類型
    • 簡介/主要發現
    • 市場規模績效分析：依樣本類型（2019-2024）
    • 按樣本類型分類的當前市場規模分析和預測（2025-2032）
    • 市場吸引力分析：樣本類型
  • 全球快速流感診斷測試（RIDT）市場展望：最終用戶
    • 簡介/主要發現
    • 按最終用戶分類的市場規模績效分析（2019-2024 年）
    • 目前市場規模分析及最終用戶預測（2025-2032）
    • 市場吸引力分析：最終用戶

5. 全球快速流感診斷測試（RIDT）市場展望（按地區）

  • 主要亮點
  • 市場規模績效分析：按地區（2019-2024）
  • 目前市場規模分析及各地區預測（2025-2032）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：地區

6. 北美快速流感診斷檢驗（RIDT）市場展望

7. 歐洲快速流感診斷檢驗（RIDT）市場展望

8. 東亞快速流感診斷檢驗（RIDT）市場展望

9. 南亞和大洋洲快速流感診斷測試（RIDT）市場展望

10. 拉丁美洲快速流感診斷檢驗（RIDT）市場展望

11.中東和非洲快速流感診斷測試（RIDT）市場展望

第12章競爭格局

  • 市場佔有率分析（2025年）
  • 市場結構
    • 競爭強度圖：按市場
    • 競爭儀錶板
  • 公司簡介（詳情－概述、財務狀況、策略、最新發展）
    • QuidelOrtho Corporation
    • BD
    • Thermo Fisher Scientific Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd
    • DiaSorin SpA
    • Meridian Life Science, Inc.
    • SEKISUI Diagnostics
    • Virax Biolabs
    • ACCESS BIO
    • Princeton BioMeditech Corporation
    • LifeSign LLC.
    • McKesson Medical-Surgical Inc.
    • Pfizer Inc.
    • EBOS Healthcare
    • KANEKA CORPORATION
    • Siemens Healthcare Private Limited
    • Healgen
    • iHealth Labs Inc.
    • SG Diagnostics
    • Flowflex UK
    • 其他

第13章 附錄

簡介目錄
Product Code: PMRREP31040

Persistence Market Research has recently released a comprehensive report on the global Rapid Influenza Diagnostic Tests (RIDTs) Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Rapid Influenza Diagnostic Tests Market Size (2025E): US$ 982.0 Mn
  • Projected Market Value (2032F): US$ 1,749.5 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.6%

Rapid Influenza Diagnostic Tests Market - Report Scope:

The Rapid Influenza Diagnostic Tests (RIDTs) market encompasses diagnostic tools designed to detect influenza viral antigens in respiratory specimens within a short time frame, often under 30 minutes. These tests are crucial in point-of-care settings for timely diagnosis and management of influenza infections, especially during seasonal outbreaks or pandemics. Technological advancements in immunoassays, growing awareness of early disease detection, and increasing global health threats have significantly contributed to the market's momentum.

Market Growth Drivers:

The growth of the global RIDTs market is largely driven by rising incidences of seasonal and pandemic influenza, which has increased the demand for rapid and accurate point-of-care diagnostics. Enhanced public health initiatives and surveillance programs by governments and healthcare agencies have amplified the focus on early detection to curb transmission. In addition, technological innovations in digital and molecular diagnostics, including the development of more sensitive and specific RIDTs, have broadened clinical applications and reliability. The growing adoption of these tests in home care settings and remote healthcare environments further accelerates their market penetration. Moreover, the global increase in geriatric populations, who are at higher risk of severe influenza complications, adds to the demand for faster and convenient diagnostics.

Market Restraints:

Despite strong demand, the RIDTs market faces notable constraints. A key limitation lies in the relatively lower sensitivity of some conventional rapid tests compared to laboratory-based methods such as RT-PCR, leading to false negatives and subsequent challenges in clinical decision-making. This limitation can hinder clinician confidence in test results, especially in critical care scenarios. Additionally, variability in test performance due to mutations in influenza viruses poses challenges to maintaining consistent diagnostic accuracy. Regulatory hurdles and product recalls can also impede market progress, particularly for new entrants aiming to commercialize innovative diagnostics. Moreover, in resource-limited settings, cost constraints and lack of awareness about the benefits of early testing can restrict the widespread adoption of RIDTs.

Market Opportunities:

Amidst these challenges, the RIDTs market presents several lucrative growth opportunities. The increasing integration of molecular diagnostics, particularly NAAT-based rapid tests, offers high sensitivity with reduced turnaround times, positioning them as a preferred alternative in clinical and non-clinical settings. Expansion of telemedicine and decentralized healthcare has opened new channels for home-based influenza testing, supported by user-friendly digital test kits. Emerging economies, particularly in Asia-Pacific and Latin America, offer untapped market potential due to rising healthcare infrastructure investments and growing awareness. Furthermore, strategic collaborations between diagnostic companies and public health organizations can foster innovation and accelerate deployment of next-generation RIDTs. The ongoing focus on pandemic preparedness and investments in infectious disease surveillance also create fertile ground for market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the global RIDTs market's growth?
  • Which regions and segments are witnessing the highest adoption of RIDTs?
  • How are technological advancements reshaping diagnostic accuracy and speed?
  • Who are the leading players in the RIDTs market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and market forecasts for the next decade?

Competitive Intelligence and Business Strategy:

Leading players in the global RIDTs market, such as QuidelOrtho Corporation, BD, Abbott, and Thermo Fisher Scientific Inc., are heavily investing in the development of advanced diagnostic platforms with improved sensitivity and faster result delivery. These companies are also focusing on expanding their geographic footprint through mergers, partnerships, and distribution agreements. Innovations such as multiplex assays capable of detecting both influenza A and B simultaneously, and digital diagnostics with smartphone connectivity, are key strategic areas. Other players, including DiaSorin S.p.A., Meridian Life Science, and Virax Biolabs, are enhancing their assay technologies and collaborating with health authorities to bolster public health preparedness. Strengthening presence in home care and remote diagnostics through user-friendly formats continues to be a central strategy for competitive differentiation.

Companies Covered in This Report:

  • QuidelOrtho Corporation
  • BD
  • Thermo Fisher Scientific Inc.
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • DiaSorin S.p.A.
  • Meridian Life Science, Inc.
  • SEKISUI Diagnostics
  • Virax Biolabs
  • ACCESS BIO
  • Princeton BioMeditech Corporation
  • LifeSign LLC.
  • McKesson Medical-Surgical Inc.
  • Pfizer Inc.

Rapid Influenza Diagnostic Tests Market Segmentation:

By Product Type:

  • Conventional
  • Digital

By Test Type:

  • Influenza A Test
  • Influenza B Test
  • Influenza A+B Test

By Assay Type:

  • Immunochromatographic Assays
  • Immunofluorescence Assays
  • Nucleic Acid Amplification Test (NAAT)

By Sample Type:

  • Throat Swab
  • Nasal Swab
  • Nasal Aspirate
  • Nasopharyngeal Swab
  • Nasopharyngeal Aspirate
  • Nasopharyngeal Wash

By End User:

  • Hospitals & Clinics
  • Diagnostic Centers & Laboratories
  • Nursing Homes
  • Home Care Settings
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Rapid Influenza Diagnostic Tests Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Technological Advancement
  • 3.4. Regulatory Landscape
  • 3.5. Value Chain Analysis
  • 3.6. Key Deals and Mergers
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Global Rapid Influenza Diagnostic Tests Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Rapid Influenza Diagnostic Tests Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) and Analysis, By Product Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.3.1. Conventional
      • 4.3.3.2. Digital
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Global Rapid Influenza Diagnostic Tests Market Outlook: Test Type
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
      • 4.4.3.1. Influenza A Test
      • 4.4.3.2. Influenza B Test
      • 4.4.3.3. Influenza A+B Test
    • 4.4.4. Market Attractiveness Analysis: Test Type
  • 4.5. Global Rapid Influenza Diagnostic Tests Market Outlook: Assay Type
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Assay Type, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
      • 4.5.3.1. Immunochromatographic Assays
      • 4.5.3.2. Immunofluorescence Assays
      • 4.5.3.3. Nucleic Acid Amplification Test (NAAT)
    • 4.5.4. Market Attractiveness Analysis: Assay Type
  • 4.6. Global Rapid Influenza Diagnostic Tests Market Outlook: Sample Type
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Mn) Analysis, By Sample Type, 2019-2024
    • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
      • 4.6.3.1. Throat Swab
      • 4.6.3.2. Nasal Swab
      • 4.6.3.3. Nasal Aspirate
      • 4.6.3.4. Nasopharyngeal Swab
      • 4.6.3.5. Nasopharyngeal Aspirate
      • 4.6.3.6. Nasopharyngeal Wash
    • 4.6.4. Market Attractiveness Analysis: Sample Type
  • 4.7. Global Rapid Influenza Diagnostic Tests Market Outlook: End User
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.7.3.1. Hospitals & Clinics
      • 4.7.3.2. Diagnostic Centers & Laboratories
      • 4.7.3.3. Nursing Homes
      • 4.7.3.4. Home Care Settings
      • 4.7.3.5. Others
    • 4.7.4. Market Attractiveness Analysis: End User

5. Global Rapid Influenza Diagnostic Tests Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Rapid Influenza Diagnostic Tests Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Test Type
    • 6.2.4. By Assay Type
    • 6.2.5. By Sample Type
    • 6.2.6. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.4.1. Conventional
    • 6.4.2. Digital
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 6.5.1. Influenza A Test
    • 6.5.2. Influenza B Test
    • 6.5.3. Influenza A+B Test
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 6.6.1. Immunochromatographic Assays
    • 6.6.2. Immunofluorescence Assays
    • 6.6.3. Nucleic Acid Amplification Test (NAAT)
  • 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 6.7.1. Throat Swab
    • 6.7.2. Nasal Swab
    • 6.7.3. Nasal Aspirate
    • 6.7.4. Nasopharyngeal Swab
    • 6.7.5. Nasopharyngeal Aspirate
    • 6.7.6. Nasopharyngeal Wash
  • 6.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.8.1. Hospitals & Clinics
    • 6.8.2. Diagnostic Centers & Laboratories
    • 6.8.3. Nursing Homes
    • 6.8.4. Home Care Settings
    • 6.8.5. Others
  • 6.9. Market Attractiveness Analysis

7. Europe Rapid Influenza Diagnostic Tests Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Test Type
    • 7.2.4. By Assay Type
    • 7.2.5. By Sample Type
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Conventional
    • 7.4.2. Digital
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 7.5.1. Influenza A Test
    • 7.5.2. Influenza B Test
    • 7.5.3. Influenza A+B Test
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 7.6.1. Immunochromatographic Assays
    • 7.6.2. Immunofluorescence Assays
    • 7.6.3. Nucleic Acid Amplification Test (NAAT)
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 7.7.1. Throat Swab
    • 7.7.2. Nasal Swab
    • 7.7.3. Nasal Aspirate
    • 7.7.4. Nasopharyngeal Swab
    • 7.7.5. Nasopharyngeal Aspirate
    • 7.7.6. Nasopharyngeal Wash
  • 7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.8.1. Hospitals & Clinics
    • 7.8.2. Diagnostic Centers & Laboratories
    • 7.8.3. Nursing Homes
    • 7.8.4. Home Care Settings
    • 7.8.5. Others
  • 7.9. Market Attractiveness Analysis

8. East Asia Rapid Influenza Diagnostic Tests Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Test Type
    • 8.2.4. By Assay Type
    • 8.2.5. By Sample Type
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Conventional
    • 8.4.2. Digital
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 8.5.1. Influenza A Test
    • 8.5.2. Influenza B Test
    • 8.5.3. Influenza A+B Test
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 8.6.1. Immunochromatographic Assays
    • 8.6.2. Immunofluorescence Assays
    • 8.6.3. Nucleic Acid Amplification Test (NAAT)
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 8.7.1. Throat Swab
    • 8.7.2. Nasal Swab
    • 8.7.3. Nasal Aspirate
    • 8.7.4. Nasopharyngeal Swab
    • 8.7.5. Nasopharyngeal Aspirate
    • 8.7.6. Nasopharyngeal Wash
  • 8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.8.1. Hospitals & Clinics
    • 8.8.2. Diagnostic Centers & Laboratories
    • 8.8.3. Nursing Homes
    • 8.8.4. Home Care Settings
    • 8.8.5. Others
  • 8.9. Market Attractiveness Analysis

9. South Asia & Oceania Rapid Influenza Diagnostic Tests Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Test Type
    • 9.2.4. By Assay Type
    • 9.2.5. By Sample Type
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Conventional
    • 9.4.2. Digital
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 9.5.1. Influenza A Test
    • 9.5.2. Influenza B Test
    • 9.5.3. Influenza A+B Test
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 9.6.1. Immunochromatographic Assays
    • 9.6.2. Immunofluorescence Assays
    • 9.6.3. Nucleic Acid Amplification Test (NAAT)
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 9.7.1. Throat Swab
    • 9.7.2. Nasal Swab
    • 9.7.3. Nasal Aspirate
    • 9.7.4. Nasopharyngeal Swab
    • 9.7.5. Nasopharyngeal Aspirate
    • 9.7.6. Nasopharyngeal Wash
  • 9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.8.1. Hospitals & Clinics
    • 9.8.2. Diagnostic Centers & Laboratories
    • 9.8.3. Nursing Homes
    • 9.8.4. Home Care Settings
    • 9.8.5. Others
  • 9.9. Market Attractiveness Analysis

10. Latin America Rapid Influenza Diagnostic Tests Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Test Type
    • 10.2.4. By Assay Type
    • 10.2.5. By Sample Type
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Conventional
    • 10.4.2. Digital
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 10.5.1. Influenza A Test
    • 10.5.2. Influenza B Test
    • 10.5.3. Influenza A+B Test
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 10.6.1. Immunochromatographic Assays
    • 10.6.2. Immunofluorescence Assays
    • 10.6.3. Nucleic Acid Amplification Test (NAAT)
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 10.7.1. Throat Swab
    • 10.7.2. Nasal Swab
    • 10.7.3. Nasal Aspirate
    • 10.7.4. Nasopharyngeal Swab
    • 10.7.5. Nasopharyngeal Aspirate
    • 10.7.6. Nasopharyngeal Wash
  • 10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.8.1. Hospitals & Clinics
    • 10.8.2. Diagnostic Centers & Laboratories
    • 10.8.3. Nursing Homes
    • 10.8.4. Home Care Settings
    • 10.8.5. Others
  • 10.9. Market Attractiveness Analysis

11. Middle East & Africa Rapid Influenza Diagnostic Tests Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Test Type
    • 11.2.4. By Assay Type
    • 11.2.5. By Sample Type
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Conventional
    • 11.4.2. Digital
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 11.5.1. Influenza A Test
    • 11.5.2. Influenza B Test
    • 11.5.3. Influenza A+B Test
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 11.6.1. Immunochromatographic Assays
    • 11.6.2. Immunofluorescence Assays
    • 11.6.3. Nucleic Acid Amplification Test (NAAT)
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 11.7.1. Throat Swab
    • 11.7.2. Nasal Swab
    • 11.7.3. Nasal Aspirate
    • 11.7.4. Nasopharyngeal Swab
    • 11.7.5. Nasopharyngeal Aspirate
    • 11.7.6. Nasopharyngeal Wash
  • 11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.8.1. Hospitals & Clinics
    • 11.8.2. Diagnostic Centers & Laboratories
    • 11.8.3. Nursing Homes
    • 11.8.4. Home Care Settings
    • 11.8.5. Others
  • 11.9. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. QuidelOrtho Corporation
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Type
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. BD
    • 12.3.3. Thermo Fisher Scientific Inc.
    • 12.3.4. Abbott
    • 12.3.5. F. Hoffmann-La Roche Ltd
    • 12.3.6. DiaSorin S.p.A.
    • 12.3.7. Meridian Life Science, Inc.
    • 12.3.8. SEKISUI Diagnostics
    • 12.3.9. Virax Biolabs
    • 12.3.10. ACCESS BIO
    • 12.3.11. Princeton BioMeditech Corporation
    • 12.3.12. LifeSign LLC.
    • 12.3.13. McKesson Medical-Surgical Inc.
    • 12.3.14. Pfizer Inc.
    • 12.3.15. EBOS Healthcare
    • 12.3.16. KANEKA CORPORATION
    • 12.3.17. Siemens Healthcare Private Limited
    • 12.3.18. Healgen
    • 12.3.19. iHealth Labs Inc.
    • 12.3.20. SG Diagnostics
    • 12.3.21. Flowflex UK
    • 12.3.22. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations